 Fredrick Rosario-Joseph
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 26 | 2023 | 639 | 4.550 |
Why?
| | Trophoblasts | 13 | 2023 | 170 | 4.370 |
Why?
| | TOR Serine-Threonine Kinases | 21 | 2023 | 369 | 3.680 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 8 | 2023 | 59 | 2.570 |
Why?
| | Fetal Growth Retardation | 10 | 2021 | 468 | 2.450 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 9 | 2023 | 104 | 2.380 |
Why?
| | Amino Acid Transport System A | 5 | 2021 | 32 | 2.090 |
Why?
| | Diabetes, Gestational | 6 | 2023 | 284 | 1.960 |
Why?
| | Folic Acid | 6 | 2021 | 161 | 1.720 |
Why?
| | Glucose Intolerance | 5 | 2022 | 139 | 1.670 |
Why?
| | Pregnancy | 40 | 2023 | 5691 | 1.450 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 48 | 1.380 |
Why?
| | Amino Acid Transport Systems | 5 | 2017 | 39 | 1.370 |
Why?
| | Adiponectin | 7 | 2022 | 226 | 1.280 |
Why?
| | Amino Acid Transport System L | 2 | 2021 | 15 | 1.260 |
Why?
| | Insulin-Like Growth Factor I | 6 | 2023 | 287 | 1.210 |
Why?
| | Fetal Weight | 4 | 2015 | 51 | 1.180 |
Why?
| | Fetal Development | 9 | 2023 | 250 | 1.160 |
Why?
| | Insulin | 10 | 2023 | 2162 | 1.160 |
Why?
| | Amino Acids | 5 | 2023 | 465 | 1.130 |
Why?
| | Multiprotein Complexes | 4 | 2015 | 149 | 0.960 |
Why?
| | Maternal Nutritional Physiological Phenomena | 6 | 2021 | 157 | 0.960 |
Why?
| | Insulin Resistance | 6 | 2022 | 1180 | 0.930 |
Why?
| | Obesity | 12 | 2023 | 2746 | 0.920 |
Why?
| | Maternal-Fetal Exchange | 3 | 2021 | 157 | 0.910 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2021 | 814 | 0.900 |
Why?
| | Cell Membrane | 6 | 2020 | 710 | 0.870 |
Why?
| | Intracellular Signaling Peptides and Proteins | 4 | 2023 | 404 | 0.860 |
Why?
| | RNA Interference | 6 | 2021 | 460 | 0.830 |
Why?
| | Diet, Protein-Restricted | 1 | 2021 | 10 | 0.820 |
Why?
| | Signal Transduction | 14 | 2020 | 4709 | 0.770 |
Why?
| | Folate Receptor 1 | 2 | 2019 | 13 | 0.760 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 25 | 0.730 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 58 | 0.710 |
Why?
| | Pregnancy Complications | 7 | 2019 | 448 | 0.640 |
Why?
| | Placental Insufficiency | 1 | 2019 | 104 | 0.620 |
Why?
| | Fetal Macrosomia | 4 | 2023 | 56 | 0.600 |
Why?
| | Leptin | 2 | 2015 | 231 | 0.600 |
Why?
| | Papio | 6 | 2021 | 92 | 0.580 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 36 | 0.570 |
Why?
| | Regulatory-Associated Protein of mTOR | 4 | 2019 | 19 | 0.570 |
Why?
| | Female | 44 | 2023 | 61565 | 0.560 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 1 | 2015 | 6 | 0.550 |
Why?
| | Fetal Nutrition Disorders | 1 | 2015 | 7 | 0.550 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2022 | 468 | 0.540 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2015 | 394 | 0.530 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 148 | 0.530 |
Why?
| | Weight Gain | 2 | 2015 | 493 | 0.490 |
Why?
| | Transfection | 2 | 2015 | 888 | 0.480 |
Why?
| | Fatty Liver | 2 | 2022 | 253 | 0.470 |
Why?
| | Nutritional Status | 1 | 2015 | 300 | 0.450 |
Why?
| | Placentation | 3 | 2021 | 43 | 0.450 |
Why?
| | Cells, Cultured | 7 | 2020 | 4077 | 0.450 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 3 | 2019 | 28 | 0.430 |
Why?
| | Animals | 29 | 2022 | 33381 | 0.430 |
Why?
| | Down-Regulation | 4 | 2017 | 627 | 0.430 |
Why?
| | Gene Targeting | 1 | 2012 | 80 | 0.430 |
Why?
| | Mice, Obese | 4 | 2022 | 58 | 0.410 |
Why?
| | Primary Cell Culture | 3 | 2019 | 155 | 0.400 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 76 | 0.370 |
Why?
| | Dietary Proteins | 1 | 2011 | 130 | 0.360 |
Why?
| | Phosphorylation | 4 | 2023 | 1633 | 0.360 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 2 | 2023 | 25 | 0.350 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 189 | 0.340 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2008 | 3 | 0.340 |
Why?
| | Proton-Coupled Folate Transporter | 2 | 2019 | 8 | 0.340 |
Why?
| | Vitamin E Deficiency | 1 | 2008 | 42 | 0.330 |
Why?
| | Gestational Age | 4 | 2021 | 765 | 0.330 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 13 | 0.320 |
Why?
| | Glucose | 4 | 2022 | 953 | 0.320 |
Why?
| | Copper | 1 | 2008 | 102 | 0.320 |
Why?
| | Micronutrients | 1 | 2008 | 79 | 0.310 |
Why?
| | Mice | 12 | 2022 | 15520 | 0.300 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 31 | 0.300 |
Why?
| | Heart Diseases | 2 | 2022 | 341 | 0.300 |
Why?
| | Disease Models, Animal | 6 | 2022 | 3730 | 0.300 |
Why?
| | Mice, Inbred C57BL | 7 | 2020 | 4908 | 0.270 |
Why?
| | Zinc | 1 | 2008 | 262 | 0.270 |
Why?
| | Biological Availability | 2 | 2023 | 126 | 0.260 |
Why?
| | Liver | 3 | 2023 | 1816 | 0.260 |
Why?
| | Serotonin | 2 | 2020 | 309 | 0.260 |
Why?
| | Biological Transport | 3 | 2021 | 382 | 0.250 |
Why?
| | Humans | 27 | 2023 | 118974 | 0.240 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 12 | 0.240 |
Why?
| | Blood Glucose | 5 | 2022 | 1939 | 0.240 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2023 | 16 | 0.240 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2022 | 178 | 0.220 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 137 | 0.220 |
Why?
| | Ubiquitination | 3 | 2022 | 87 | 0.220 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2445 | 0.220 |
Why?
| | Overnutrition | 1 | 2022 | 39 | 0.210 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 15 | 0.190 |
Why?
| | Organogenesis | 1 | 2021 | 54 | 0.190 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 220 | 0.190 |
Why?
| | Embryonic Development | 1 | 2021 | 118 | 0.190 |
Why?
| | RNA, Small Interfering | 2 | 2012 | 564 | 0.180 |
Why?
| | Reduced Folate Carrier Protein | 1 | 2019 | 8 | 0.180 |
Why?
| | Carrier Proteins | 3 | 2017 | 726 | 0.180 |
Why?
| | Hypertension | 1 | 2008 | 1203 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2022 | 420 | 0.170 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 15 | 0.170 |
Why?
| | Electron Transport | 1 | 2019 | 101 | 0.170 |
Why?
| | Gene Silencing | 2 | 2016 | 177 | 0.160 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 156 | 0.160 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 24 | 0.150 |
Why?
| | Docosahexaenoic Acids | 1 | 2017 | 70 | 0.150 |
Why?
| | Metabolic Diseases | 1 | 2018 | 103 | 0.150 |
Why?
| | Protein Transport | 2 | 2015 | 412 | 0.150 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 111 | 0.150 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 10 | 0.150 |
Why?
| | Homocysteine | 1 | 2017 | 137 | 0.150 |
Why?
| | Food Deprivation | 1 | 2016 | 24 | 0.140 |
Why?
| | Homeostasis | 1 | 2020 | 594 | 0.140 |
Why?
| | Maternal Age | 1 | 2016 | 122 | 0.140 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.140 |
Why?
| | PPAR alpha | 2 | 2015 | 56 | 0.140 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 13 | 0.140 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2015 | 18 | 0.140 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 62 | 0.130 |
Why?
| | Placental Circulation | 1 | 2015 | 56 | 0.130 |
Why?
| | Up-Regulation | 2 | 2015 | 872 | 0.130 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2015 | 66 | 0.130 |
Why?
| | Diet, High-Fat | 2 | 2022 | 247 | 0.130 |
Why?
| | Caloric Restriction | 1 | 2015 | 89 | 0.120 |
Why?
| | Casein Kinase II | 1 | 2014 | 21 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 315 | 0.120 |
Why?
| | Dietary Supplements | 1 | 2017 | 467 | 0.120 |
Why?
| | Fatty Acids | 2 | 2022 | 407 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 296 | 0.120 |
Why?
| | Enzyme Activation | 1 | 2015 | 828 | 0.120 |
Why?
| | Mitochondria | 1 | 2019 | 786 | 0.110 |
Why?
| | Adult | 7 | 2022 | 31512 | 0.110 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 15 | 0.110 |
Why?
| | Lentivirus | 1 | 2012 | 52 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2015 | 502 | 0.110 |
Why?
| | Lipid Metabolism | 1 | 2015 | 477 | 0.110 |
Why?
| | Receptors, Adiponectin | 1 | 2012 | 14 | 0.110 |
Why?
| | Dependovirus | 1 | 2012 | 52 | 0.110 |
Why?
| | Leucine | 1 | 2012 | 117 | 0.110 |
Why?
| | DNA Methylation | 1 | 2016 | 503 | 0.100 |
Why?
| | Male | 11 | 2022 | 57801 | 0.100 |
Why?
| | Embryo Implantation | 2 | 2001 | 24 | 0.100 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.100 |
Why?
| | Endometrium | 2 | 2001 | 61 | 0.100 |
Why?
| | Young Adult | 4 | 2019 | 10793 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 341 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1798 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2015 | 767 | 0.090 |
Why?
| | Rats | 3 | 2021 | 5392 | 0.090 |
Why?
| | Mothers | 1 | 2015 | 682 | 0.090 |
Why?
| | Phosphoproteins | 1 | 2011 | 308 | 0.080 |
Why?
| | Proteolysis | 2 | 2022 | 146 | 0.080 |
Why?
| | Systole | 1 | 2008 | 168 | 0.080 |
Why?
| | PPAR gamma | 2 | 2022 | 188 | 0.080 |
Why?
| | Body Weight | 1 | 2012 | 934 | 0.080 |
Why?
| | Boswellia | 1 | 2007 | 1 | 0.080 |
Why?
| | Reproduction | 1 | 2008 | 189 | 0.070 |
Why?
| | Transcriptome | 1 | 2022 | 756 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2022 | 5255 | 0.070 |
Why?
| | Lipids | 2 | 2022 | 607 | 0.070 |
Why?
| | MicroRNAs | 1 | 2012 | 637 | 0.070 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2007 | 211 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 165 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2021 | 399 | 0.060 |
Why?
| | Diet | 1 | 2011 | 1153 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1515 | 0.060 |
Why?
| | Adult Children | 1 | 2022 | 18 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 2 | 2001 | 219 | 0.050 |
Why?
| | Fetal Heart | 1 | 2022 | 29 | 0.050 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 103 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 35 | 0.050 |
Why?
| | Carnitine | 1 | 2022 | 65 | 0.050 |
Why?
| | Birth Weight | 2 | 2017 | 465 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3171 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 368 | 0.050 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 98 | 0.050 |
Why?
| | Cardiomegaly | 1 | 2022 | 168 | 0.050 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 25 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 311 | 0.050 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2001 | 86 | 0.050 |
Why?
| | Umbilical Cord | 1 | 2020 | 84 | 0.050 |
Why?
| | Adipocytes | 1 | 2022 | 199 | 0.050 |
Why?
| | Microvilli | 1 | 2019 | 70 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 1 | 2019 | 70 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2019 | 126 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1032 | 0.040 |
Why?
| | Body Mass Index | 2 | 2019 | 2092 | 0.040 |
Why?
| | Microscopy, Electron | 3 | 2007 | 413 | 0.040 |
Why?
| | Anti-Infective Agents | 1 | 2001 | 227 | 0.040 |
Why?
| | Phagosomes | 1 | 2017 | 43 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 5116 | 0.040 |
Why?
| | Blood Platelets | 1 | 2020 | 369 | 0.040 |
Why?
| | Hormones | 1 | 2017 | 135 | 0.040 |
Why?
| | Lysosomes | 1 | 2017 | 136 | 0.040 |
Why?
| | Echocardiography | 1 | 2019 | 556 | 0.040 |
Why?
| | Fetus | 1 | 2020 | 690 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2018 | 806 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 2017 | 125 | 0.030 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 4 | 0.030 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2015 | 42 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1474 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2015 | 73 | 0.030 |
Why?
| | Transport Vesicles | 1 | 2015 | 19 | 0.030 |
Why?
| | Dietary Sucrose | 1 | 2015 | 55 | 0.030 |
Why?
| | Lipase | 1 | 2015 | 70 | 0.030 |
Why?
| | Heart | 1 | 2019 | 631 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 139 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 97 | 0.030 |
Why?
| | Organ Size | 1 | 2015 | 460 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2014 | 73 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 106 | 0.030 |
Why?
| | Receptor, IGF Type 1 | 1 | 2014 | 59 | 0.030 |
Why?
| | Myocardium | 1 | 2019 | 970 | 0.030 |
Why?
| | Pregnancy, Animal | 1 | 2014 | 57 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 174 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2424 | 0.030 |
Why?
| | Hepatocytes | 1 | 2014 | 205 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 827 | 0.030 |
Why?
| | Administration, Intravaginal | 2 | 2001 | 21 | 0.030 |
Why?
| | Macaca mulatta | 2 | 2001 | 153 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 6471 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 1900 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1715 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2657 | 0.020 |
Why?
| | Alloxan | 1 | 2007 | 4 | 0.020 |
Why?
| | Pancreas, Exocrine | 1 | 2007 | 8 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2007 | 32 | 0.020 |
Why?
| | Plant Roots | 1 | 2007 | 39 | 0.020 |
Why?
| | Urea | 1 | 2007 | 77 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 69 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2007 | 157 | 0.020 |
Why?
| | Plant Leaves | 1 | 2007 | 118 | 0.020 |
Why?
| | Epithelial Cells | 2 | 2001 | 963 | 0.020 |
Why?
| | Anticholesteremic Agents | 1 | 2007 | 130 | 0.020 |
Why?
| | Cholesterol | 1 | 2007 | 373 | 0.020 |
Why?
| | Creatinine | 1 | 2007 | 491 | 0.020 |
Why?
| | Triglycerides | 1 | 2007 | 519 | 0.020 |
Why?
| | Endothelium, Vascular | 2 | 2001 | 907 | 0.020 |
Why?
| | Cyclohexanes | 1 | 2001 | 22 | 0.010 |
Why?
| | Sesquiterpenes | 1 | 2001 | 51 | 0.010 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2001 | 78 | 0.010 |
Why?
| | Progesterone | 1 | 2001 | 242 | 0.010 |
Why?
| | Estradiol | 1 | 2001 | 476 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 6412 | 0.010 |
Why?
| | Peptides | 1 | 2001 | 879 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9342 | 0.010 |
Why?
|
|
Rosario-Joseph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|